Skip to content

Clinical trials

Phase 2 trials in Burkina Faso

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Country / region: Burkina Faso Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20071
20081
20091
20112
20132
20152
20161
20171
20182
20191
20211
20221
20232
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting4
Terminated4
Active, not recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Heidelberg University6
Sanofi5
ANRS, Emerging Infectious Diseases2
French National Agency for Research on AIDS and Viral Hepatitis2
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2
University of Oxford2
Janssen Vaccines & Prevention B.V.1
Kathleen Neuzil1
PATH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Malaria, Falciparum14
Malaria10
HIV Infections3
Typhoid Fever2
Acquired Immunodeficiency Syndrome1
Asymptomatic Infections1
Elimination Disorders1
Hemorrhagic Fever, Ebola1
Hemorrhagic Fevers, Viral1
Herpes Genitalis1

Trials

Showing 26 to 33 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.